[
  {
    "ts": null,
    "headline": "Viatris Says FDA Approves Octreotide Acetate, Clears MR-146 for Clinical Trials",
    "summary": "Viatris (VTRS) said Thursday the US Food and Drug Administration approved octreotide acetate for inj",
    "url": "https://finnhub.io/api/news?id=832fa7c277c15b62bf3bf5ac7c8a98fa645ab2d5dcd1986e33b48a448664e72d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766063687,
      "headline": "Viatris Says FDA Approves Octreotide Acetate, Clears MR-146 for Clinical Trials",
      "id": 137822148,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "Viatris (VTRS) said Thursday the US Food and Drug Administration approved octreotide acetate for inj",
      "url": "https://finnhub.io/api/news?id=832fa7c277c15b62bf3bf5ac7c8a98fa645ab2d5dcd1986e33b48a448664e72d"
    }
  },
  {
    "ts": null,
    "headline": "Viatris Provides Pipeline Update on Four Regulatory Milestones",
    "summary": "Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced four recent regulatory milestones spanning across all stages of its global pipeline:",
    "url": "https://finnhub.io/api/news?id=4a417a0313eaa045c5aa9b59359ac5db2827d273fb3703f813821eb23526dc38",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1766059140,
      "headline": "Viatris Provides Pipeline Update on Four Regulatory Milestones",
      "id": 137822149,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced four recent regulatory milestones spanning across all stages of its global pipeline:",
      "url": "https://finnhub.io/api/news?id=4a417a0313eaa045c5aa9b59359ac5db2827d273fb3703f813821eb23526dc38"
    }
  }
]